Selective N-type calcium channel antagonist omega conotoxin MVIIA is neuroprotective against hypoxic neurodegeneration in organotypic hippocampal- slice cultures

Stroke

Volumn 27, Issue 11, 1996, Pages 2124-2130

  Pringle, A K ^a   Benham, C D ^b   Sim, L ^a   Kennedy, J ^a   Iannotti, F ^a   Sundstrom, L E ^a,c  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b GLAXOSMITHKLINE   (United Kingdom)

^c SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

Author keywords

calcium channel blockers; hippocampus; hypoxia; neuroprotection; rats

Indexed keywords

CALCIUM CHANNEL; CALCIUM CHANNEL BLOCKING AGENT; DIHYDROPYRIDINE; GLUCOSE; NIFEDIPINE; OMEGA CONOTOXIN MVIIA; OMEGA CONOTOXIN MVIIC; OXYGEN; SB 201823A; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; BRAIN ISCHEMIA; BRAIN PROTECTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; HIPPOCAMPUS; HYPOXIA; NERVE CELL DEGENERATION; NERVE CELL LESION; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; RAT;

EID: 0029834061     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.27.11.2124     Document Type: Article

References (35)

1. Choi DW. Cerebral hypoxia: some new approaches and unanswered questions. J Neurosci. 1990;10:2493-2501.
2. Choi DW. NMDA receptors and AMPA/kainate receptors mediate parallel injury in cerebral cortical cultures subjected to oxygen-glucose deprivation. Prog Brain Res. 1993;96:137-143.
3. Dessi F, Charriaut-Marlangue C, Ben-Ari Y. Glutamate-induced neuronal death in cerebellar culture is mediated by two distinct components: a sodium-chloride component and a calcium component. Brain Res. 1994;650:49-55.
4. Choi DW. Glutamate neurotoxicity in cortical culture is calcium dependent. Neurosci Lett. 1985;58:293-297.
5. Goldberg MP, Choi DW. Combined oxygen and glucose deprivation in cortical cell culture: calcium dependent and calcium independent mechanisms of neuronal injury. J Neurosci. 1993;13:3510-3524.
6. Weiss JH, Hartley DM, Koh J, Choi DW. The calcium channel blocker nifedipine attenuates slow excitatory amino acid neurotoxicity. Science. 1990;247:1474-1477.
7. Sucher NJ, Lei SZ, Lipton SA. Calcium channel antagonists attenuate NMDA receptor-mediated neurotoxicity of retinal ganglion cells in culture. Brain Res. 1991;297:297-302.
8. Olney JW. Brain lesion, obesity and other disturbances in mice treated with monosodium glutamate. Science. 1969;164:719-721.
9. Madden KP, Clark WM, Marcoux FW, Probert AW, Weber ML, Rivier J, Zivin JA. Treatment with conotoxin, an 'N-type' calcium channel blocker in neuronal hypoxic-ischemic injury. Brain Res. 1990;537:256-262.
10. Bielenberg GW, Beck T. The effects of dizocilpine (MK-801), phencyclidine and nimodipine on infarct size 48 h after middle cerebral artery occlusion in the rat. Brain Res. 1991;552:338-342.
11. Valentino K, Newcomb R, Gadbois T, Singh T, Bowersox S, Bitner S, Justice A, Yamashiro D, Hoffman BB, Ciaranello R, Miljanich G, Ramachandran J. A selective N-type calcium channel antagonist protects against neuronal loss after global cerebral ischemia. Proc Natl Acad Sci U S A. 1993;90:7894-7897.
12. Li Y, Kawamura S, Yasui N, Shirasawa M, Fukasawa H. Therapeutic effects of nilvadipine on rat focal cerebral ischemia. Exp Brain Res. 1994;99:1-6.
13. Buchs P-A, Stoppini L, Muller D. Structural modifications associated with synaptic development in area CA1 of rat hippocampal organotypic cultures. Dev Brain Res. 1993;71:81-91.
14. Gahwiler BH. Development of the hippocampus in vitro: cell types, synapses and receptors. Neuroscience. 1984;11:751-760.
15. Newell DW, Malouf AT, Franck JE. Glutamate mediated selective vulnerability to ischemia is present in organotypic cultures of hippocampus. Neurosci Lett. 1990;116:325-330.
16. Newell DW, Barth A, Malouf AT. Glycine site NMDA receptor antagonists provide protection against ischemia-induced neuronal damage in hippocampal slice cultures. Brain Res. 1995;675:38-44.
17. Vornov JJ, Tasker R, Coyle JT, Koroshetz WJ. Delayed protection by MK-801 and tetrodotoxin in a rat organotypic hippocampal culture model of ischemia. Stroke. 1994;25:457-465.
18. Strasser U, Fischer G. Quantitative measurement of neuronal degeneration in organotypic hippocampal cultures after combined oxygen/ glucose deprivation. J Neurosci Methods. 1995;57:177-186.
19. Strasser U, Fischer G. Protection from neuronal damage induced by combined oxygen and glucose deprivation in organotypic hippocampal cultures by glutamate receptor antagonists. Brain Res. 1995; 687:167-174.
20. Sundstrom LE, Pringle AK, Wilde GJC, Iannotti F. Ischemia in vitro? Pharmacological characterization of the effects of combined hypoxia and hypoglycemia on organotypic hippocampal slice cultures. J Cereb Blood Flow Metab. 1995;15(suppl 1):S11. Abstract.
21. Stoppini L, Buchs PA, Muller D. A simple method for organotypic cultures of nervous system. J Neurosci Methods. 1991;37:173-182.
22. Vornov JJ, Tasker RC, Coyle JT. Direct observation of the agonist specific regional vulnerability to glutamate, NMDA and kainate neurotoxicity in organotypic hippocampal cultures. Exp Neural. 1991; 114:11-22.
23. Buchan AM, Gertler SZ, Li H, Xue D, Huang Z-G, Chaundy KE, Barnes K, Lesiuk HJ. A selective N-type Ca2+ channel blocker prevents CA1 injury 24 h following severe forebrain ischemia and reduces infarction following focal ischemia. J Cereb Blood Flow Metab. 1994;14:903-910.
24. Fox JA. Irreversible and reversible blockade of IMR32 calcium channel currents by synthetic MVIIA and iodinated MVIIC omega-conopeptides. Pflugers Arch Eur J Physiol. 1995;429:873-875.
25. Fox JA. Novel omega conopeptides reduce field potential amplitudes in the rat hippocampal slice. Neurosci Lett. 1994;165:157-160.
26. Bowman D, Alexander S, Lodge D. Pharmacological characterisation of the calcium channels coupled to the plateau phase of KC1-induced free calcium elevated in chick and rat synaptosomes. Neuropharmacology. 1993;32:195-202.
27. Wheeler DB, Randall A, Tsien RW. Roles of N-type and Q-type Ca2+ channels in supporting hippocampal synaptic transmission. Science. 1994;264:107-111.
28. Gaur S, Newcomb R, Rivnay B, Bell JR, Ramachandran J, Miljanich GP. Calcium channel antagonist peptides define several components of transmitter release in the hippocampus. Neuropharmacology. 1994;33:1211-1219.
29. Takahashi T, Momiyama A. Different types of calcium channels mediate central synaptic transmission. Nature. 1993;366:156-158.
30. Small DL, Monette R, Mealing G, Buchan AM, Morley P. Neuroprotective effects of omega-Aga-IVA against in vitro ischemia in rat hippocampal slice. Neuroreport. 1995;6:1617-1620.
31. Westenbroek RE, Hell JW, Warner C. Dubel SJ, Snutch TP, Catteral WA. Biochemical properties and subcellular distribution of an N-type calcium channel alpha1 subunit. Neuron. 1992;9:1099-1115.
32. Markram H, Helm PJ, Sakmann B. Dendritic calcium transients evoked by single back-propagating action potentials in rat neocortical pyramidal cells. J Physiol (Lond). 1995;485:1-20.
33. Bowersox SS, Singh T, Nadasdi L, Zukowska-Grojec Z, Valentino K, Hoffman BB. Cardiovascular effects of omega-conopeptides in conscious rats: mechanisms of action. J Cardiovasc Pharmacol. 1992;20:756-764.
34. Benham CD, Brown TH, Cooper DG, Evans ML, Harries MH, Herdon HJ, Meakin JE, Murkitt KL, Patel SR, Roberts JC, Rothaul AL, Smith SJ, Wood N, Hunter AJ. SB201823-A, a neuronal Ca2+ antagonist is neuroprotective in two models of cerebral ischemia. Neuropharmacology: 1993;32:1249-1257.
35. Barone FC, Lysko PG, Price WJ, Feuerstein G, Al-Baracanji KA, Benham CD, Harrison DC, Harries MH, Bailey SJ, Hunter AJ. SB 201823-A antagonizes calcium currents in central neurons and reduces the effects of focal ischemia in rats in rats and mice. Stroke. 1995;26:1683-1690.